An interventional study of dexametedomidine and Bupivacain in Post Operative Pain, Acute and Arthroscopic Shoulder Surgery, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-07-01.
Sponsored by Ain Shams University · Not applicable, Interventional, and Other
Comparison between dexametidomedine\bupivacaine and plain bupivacaine in superior trunk block for arthroscopic shoulder surgeries
This study will be conducted to investigate the efficacy of adding dexmedetomidine in STB for postoperative analgesia in patients undergoing arthroscopic shoulder surgery.
Inclusion Criteria:
Exclusion Criteria:
Study groups:
The patients will be randomized into 2 groups:
Primary outcome:
Duration of analgesia of Superior trunck block.
Secondary outcome:
5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.
This study's enrollment of 40 is below the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
group administered Ultrasound guided STB with bupivacaine
Drug: Bupivacain
group administered Ultrasound guided STB with bupivacaine and dexametidomedine.
Drug: dexametedomidine · Drug: Bupivacain
1\. Group DB: are administered Ultrasound guided STB with bupivacaine and dexametidomedine.
2\. Group B: are administered Ultrasound guided STB with bupivacaine.
Duration of analgesia of Superior trunck block.
The DOA will be defined as the time interval between STB and the first need for the rescue analgesics.
Time frame: 24 hours
This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ain Shams University